STOCK TITAN

[Form 3] Perspective Therapeutics, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Joel Sendek, serving as Chief Financial Officer and a director of Perspective Therapeutics, Inc. (CATX), filed an initial Form 3 reporting the 09/04/2025 event date. The filing states that the reporting person does not beneficially own any securities of the issuer. The form references Exhibit 24 (Power of Attorney) and was signed via attorney-in-fact on 09/05/2025.

Joel Sendek, in qualità di Chief Financial Officer e di amministratore di Perspective Therapeutics, Inc. (CATX), ha presentato un Modulo iniziale Form 3 riportando la data dell'evento 09/04/2025. La presentazione indica che la persona che segnala non detiene in modo vantaggioso alcun titolo dell'emittente. Il modulo fa riferimento a Exhibit 24 (Power of Attorney) ed è stato firmato tramite attorney-in-fact il 09/05/2025.

Joel Sendek, desempeñando el cargo de Director Financiero (CFO) y director de Perspective Therapeutics, Inc. (CATX), presentó un Formulario 3 inicial reportando la fecha del evento 09/04/2025. La presentación indica que la persona informante no posee de forma ventajosa ningún valor mueble del emisor. El formulario hace referencia a Exhibit 24 (Poder Notarial) y fue firmado por un apoderado en 09/05/2025.

Joel Sendek최고재무책임자(CFO)Perspective Therapeutics, Inc. (CATX)의 이사로서 초기 Form 3를 제출하여 2025-09-04의 이벤트 날짜를 보고했습니다. 제출서에는 보고 당사자가 발행회사의 증권을 실질적으로 소유하지 않음이 명시되어 있습니다. 이 양식은 Exhibit 24 (Power of Attorney)를 참조하며, 2025-09-05에 대리인에 의해 서명되었습니다.

Joel Sendek, exerçant la fonction de directeur financier (CFO) et administrateur de Perspective Therapeutics, Inc. (CATX), a déposé un Formulaire 3 initial indiquant la date de l’événement 09/04/2025. Le dépôt précise que la personne déclarant ne détient pas, de manière bénéficiaire, de titres de l’émetteur. Le formulaire fait référence à Exhibit 24 (Power of Attorney) et a été signé par procuration le 09/05/2025.

Joel Sendek, der als Chief Financial Officer und Direktor von Perspective Therapeutics, Inc. (CATX) tätig ist, hat ein erstes Form 3 eingereicht und das Ereignisdatum 09/04/2025 gemeldet. Das Formular gibt an, dass der meldende Person keine wirtschaftlich berechtigten Anteile am Emittenten hält. Im Formular wird auf Exhibit 24 (Power of Attorney) verwiesen und wurde durch einen Bevollmächtigten am 09/05/2025 unterzeichnet.

Joel Sendek، الذي يشغل منصب الرئيس التنفيذي للمالية (CFO) وعضو مجلس إدارة في Perspective Therapeutics, Inc. (CATX)، قدم نموذج Form 3 أولي يبيّن تاريخ الحدث 09/04/2025. يذكر البيان أن الشخص المبلّغ لا يمتلك بشكل فعّال أي أوراق مالية تخص المصدر. يشير النموذج إلى Exhibit 24 (Power of Attorney) وتم التوقيع بواسطة وكيل بتاريخ 09/05/2025.

Joel Sendek,担任 首席财务官并且是 Perspective Therapeutics, Inc. (CATX)的董事,提交了一个初始 Form 3,事件日期为2025/09/04。该申报表指出报告人对发行人不直接持有任何证券。该表格引用了Exhibit 24(授权书),并于2025/09/05由代理人签署。

Positive
  • None.
Negative
  • None.

Joel Sendek, in qualità di Chief Financial Officer e di amministratore di Perspective Therapeutics, Inc. (CATX), ha presentato un Modulo iniziale Form 3 riportando la data dell'evento 09/04/2025. La presentazione indica che la persona che segnala non detiene in modo vantaggioso alcun titolo dell'emittente. Il modulo fa riferimento a Exhibit 24 (Power of Attorney) ed è stato firmato tramite attorney-in-fact il 09/05/2025.

Joel Sendek, desempeñando el cargo de Director Financiero (CFO) y director de Perspective Therapeutics, Inc. (CATX), presentó un Formulario 3 inicial reportando la fecha del evento 09/04/2025. La presentación indica que la persona informante no posee de forma ventajosa ningún valor mueble del emisor. El formulario hace referencia a Exhibit 24 (Poder Notarial) y fue firmado por un apoderado en 09/05/2025.

Joel Sendek최고재무책임자(CFO)Perspective Therapeutics, Inc. (CATX)의 이사로서 초기 Form 3를 제출하여 2025-09-04의 이벤트 날짜를 보고했습니다. 제출서에는 보고 당사자가 발행회사의 증권을 실질적으로 소유하지 않음이 명시되어 있습니다. 이 양식은 Exhibit 24 (Power of Attorney)를 참조하며, 2025-09-05에 대리인에 의해 서명되었습니다.

Joel Sendek, exerçant la fonction de directeur financier (CFO) et administrateur de Perspective Therapeutics, Inc. (CATX), a déposé un Formulaire 3 initial indiquant la date de l’événement 09/04/2025. Le dépôt précise que la personne déclarant ne détient pas, de manière bénéficiaire, de titres de l’émetteur. Le formulaire fait référence à Exhibit 24 (Power of Attorney) et a été signé par procuration le 09/05/2025.

Joel Sendek, der als Chief Financial Officer und Direktor von Perspective Therapeutics, Inc. (CATX) tätig ist, hat ein erstes Form 3 eingereicht und das Ereignisdatum 09/04/2025 gemeldet. Das Formular gibt an, dass der meldende Person keine wirtschaftlich berechtigten Anteile am Emittenten hält. Im Formular wird auf Exhibit 24 (Power of Attorney) verwiesen und wurde durch einen Bevollmächtigten am 09/05/2025 unterzeichnet.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Sendek Joel

(Last) (First) (Middle)
C/O PERSPECTIVE THERAPEUTICS, INC.
2401 ELLIOTT AVENUE, SUITE 320

(Street)
SEATTLE WA 98121

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/04/2025
3. Issuer Name and Ticker or Trading Symbol
Perspective Therapeutics, Inc. [ CATX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
1. No securities are benefically owned. 2. Exhibit 24 - Power of Attorney.
No securities are beneficially owned.
/s/ Joel Sendek by Chris Nenno, as Attorney-in-Fact 09/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Joel Sendek report on the Form 3 for Perspective Therapeutics (CATX)?

The Form 3 reports that Joel Sendek (CFO and director) does not beneficially own any securities of Perspective Therapeutics as of the 09/04/2025 event date.

What is the filing date and signature information on the Form 3?

The document shows the event date 09/04/2025 and was signed by attorney-in-fact Chris Nenno on behalf of Joel Sendek on 09/05/2025.

Does the Form 3 include any derivative or non-derivative securities holdings?

No. The filing explicitly states that no securities are beneficially owned, and both Table I and Table II contain no reported holdings.

Is there a power of attorney referenced in the Form 3 for CATX?

Yes. The filing references Exhibit 24, which is the Power of Attorney used to sign the form.

What position does Joel Sendek hold at Perspective Therapeutics according to the filing?

The Form 3 lists Joel Sendek as a Director and as an Officer with the title Chief Financial Officer.
Perspective Therapeutics Inc

NYSE:CATX

CATX Rankings

CATX Latest News

CATX Latest SEC Filings

CATX Stock Data

230.96M
60.25M
18.82%
58.72%
8.58%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SEATTLE